Our study demonstrated for the first time, as the authors are aware, that sleep quality improvement can enhance the neuropsychological status and reduce blood Aβ42/40 ratio and Tau-pT181 levels in MCI patients due to Alzheimer’s disease. This evidence concerns the gene MAPT and Alzheimer disease.